- Citation:
- Stat Med vol 41 (22) 4340-4366
- Year:
- 2022
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-internal-user
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- Yes
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 12
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171, UG1CA283338, UG1CA189824, UG1CA233338, U10CA140158, UG1CA233331, U10CA180867, R35CA197734, UG1CA189850, 5P30CA016058, P50 CA140158
- Corr. Author:
- Authors:
- Han Fu Deedra Nicolet Krzysztof Mrózek Richard M. Stone Ann‐Kathrin Eisfeld John C. Byrd Kellie J. Archer
- Networks:
- LAPS-MA036, LAPS-OH007, OH070
- Study
- Alliance-A152010
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-20202, CALGB-8461, CALGB-9665
- Phases:
- N/A, N/A
- Keywords:
- cure fraction, expectation‐maximization, false discovery rate, forward stagewise, survival analysis